Global Melasma Treatment Market, By Type (Epidermal, Dermal, Mixed, Others), Treatment Type (Medication, Laser Treatment, Skin Peels, Others), Route of Administration (Oral, Topical), End- Users (Hospitals, Homecare, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Industry Trends and Forecast to 2030.
Melasma Treatment Market Analysis and Size
Melasma is a common skin condition characterized by the appearance of dark, discolored patches on the skin. It primarily affects the face, although it can also occur on other sun-exposed areas of the body, such as the forearms and neck. Melasma is more prevalent in women, particularly those with darker skin tones, but it can affect men as well. The exact cause of melasma is not fully understood, but several factors are believed to contribute to its development. These factors include hormonal changes, particularly during pregnancy or while taking hormonal contraceptives, exposure to ultraviolet (UV) radiation from the sun or tanning beds, and genetic predisposition. Hormonal fluctuations and UV exposure are thought to stimulate the production of melanin, the pigment responsible for skin color, leading to the formation of melasma patches.
Data Bridge Market Research analyses that the global melasma treatment market, which was USD 2,853.64 million in 2022, would rocket up to USD 4,830.25 million by 2030, and is expected to undergo a CAGR of 6.8% during the forecast period. This indicates that the market value of acute melasma dominates the product type segment of the global melasma treatment market owing to the increasing aging population. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Melasma Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (Epidermal, Dermal, Mixed, Others), Treatment Type (Medication, Laser Treatment, Skin Peels, Others), Route of Administration (Oral, Topical), End- Users (Hospitals, Homecare, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
|
|
Countries Covered
|
U.S., Canada, and Mexico in North America, Germany, Italy, the U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, the Rest of Europe in Europe, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Glenmark Pharmaceuticals Ltd (India), Abbott (U.S.), La Pristine Bioceuticals Pvt Ltd (India), Galderma Laboratories (Switzerland), Sun Pharmaceutical Industries Ltd (India), Teva Pharmaceuticals Inc. (U.S.), Wockhardt (India), mesoestetic (India), LUTRONIC (South Korea), Cynosure Inc. (U.S.), Focus Medical (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Melasma also referred to as chloasma faciei is a pigmentary skin disorder that causes brown patches on the face, especially on the bridge of the nose, cheeks, forehead and chin. It is more common in females than males and can also can appear on other parts of the body that get lots of sun. Hormone changes, particularly due to pregnancy and birth control pills, along with sun exposure, are the most common triggers for melisma.
Melasma Treatment Market Dynamics
Drivers
- Increasing prevalence of melasma
The rising incidence of melasma worldwide is a significant driver for the market. Factors such as hormonal changes, sun exposure, and genetic predisposition contribute to the development of melasma. As the prevalence of melasma continues to increase, the demand for effective treatment options also grows.
- Growing awareness and patient education
There is an increasing awareness among individuals about melasma and its impact on appearance and self-esteem. This awareness drives patients to seek treatment options to manage and reduce the visibility of melasma patches. Improved patient education through various channels, including online resources and awareness campaigns, also contributes to market growth.
- Technological advancements in laser therapy
Laser technologies, such as fractional laser and intense pulsed light (IPL), have shown promising results in treating melasma. These technologies target and break down excess melanin in the skin, reducing the appearance of melasma patches. As technological advancements continue to enhance the efficacy and safety of laser therapy, the demand for these treatments increases, driving market growth.
- Increasing focus on aesthetics and skincare
The growing emphasis on aesthetics, beauty, and skincare plays a significant role in the expansion of the market. People are increasingly concerned about their appearance and seek treatments to improve their skin tone and reduce pigmentation issues. The availability of effective melasma treatments caters to this demand and propels the market growth.
Opportunity
- Rising disposable income
Increasing disposable income in many regions allows individuals to spend more on cosmetic and dermatological procedures. As affordability improves, more people can access and afford melasma treatment options, driving market growth.
- Advancements in treatment options
The development of innovative and effective treatment options for melasma drives market growth. Researchers and pharmaceutical companies are continually exploring new therapies, topical creams, chemical peels, and laser technologies to improve the outcomes of melasma treatment. Advancements in treatment options provide more choices for patients and expand the market.
Restraints/Challenges
- Limited treatment efficacy
Melasma can be a challenging condition to treat, and not all treatment options deliver consistent and satisfactory results for all patients. The effectiveness of various treatments can vary, and some individuals may not respond adequately to available therapies. This limitation can affect patient satisfaction and hinder the market growth.
- Side effects and complications
Certain treatment modalities, such as topical creams or chemical peels, may be associated with side effects or complications. For example, topical creams containing hydroquinone may cause skin irritation or hypersensitivity reactions in some individuals. Chemical peels and laser therapies can also lead to temporary or long-term skin discoloration, redness, or scarring if not performed correctly. Concerns regarding potential side effects and complications can deter some individuals from seeking treatment.
This global melasma treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the melasma Treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
Recent Development
- In March 2023, Candela, a Canadian medical device company, announced that the picosecond laser system was approved both by the FDA and by Health Canada on Wednesday.Previously, the laser system had been approved for several indications, including acne scarring, benign pigmented lesions, tattoo removal, and wrinkles
- In January 2023, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the launch of the long-awaited SkinMedica® Even & Correct Collection. Clinically proven and formulated to deliver targeted results, these three products work separately and together to even skin tone and reduce the appearance of hyperpigmentation and dark spots on the face.
Global Melasma Treatment Market Scope
The global melasma treatment market is segmented on the basis of type, treatment type, route of administration, end users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Epidermal
- Dermal
- Mixed
- Others
Treatment Type
- Medication
- Laser Treatment
- Skin Peels
- Others
Route of Administration
- Oral
- Topical
End User
- Hospitals
- Homecare
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Melasma Treatment Market Regional Analysis/Insights
The global melasma treatment market is analyzed, and market size insights and trends are provided by country, type, treatment type, route of administration, end users, and distribution channel as referenced above.
The countries covered in the melasma treatment market report are the U.S., Canada and Mexico in North America, Germany, Italy, the U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the global melasma treatment market because of the increasing prevalence of melasma, growing investment in healthcare infrastructure is also boosting the growth of the market.
Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The melasma treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global melasma treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global melasma treatment market. The data is available for historic period 2015-2020.
Competitive Landscape and Melasma Treatment Market Share Analysis
The global melasma treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the global melasma treatment market.
Some of the major players operating in the global melasma treatment market are:
- Glenmark Pharmaceuticals Ltd (India)
- Abbott (U.S.)
- La Pristine Bioceuticals Pvt Ltd (India)
- Galderma Laboratories (Switzerland)
- Sun Pharmaceutical Industries Ltd (India)
- Teva Pharmaceuticals Inc. (U.S.)
- Wockhardt (India)
- mesoestetic (India)
- LUTRONIC (South Korea)
- Cynosure Inc. (U.S.)
- Focus Medical (U.S.)
SKU-